Business
With Biogen’s multiple sclerosis portfolio facing more generic pressure than ever, the company is eyeing a busy late-stage pipeline and hunting for deals to build its return to growth.
FEATURED STORIES
Analysts parsed the limited data available for Pfizer’s obesity candidate on the pharma’s fourth-quarter earnings call Tuesday, looking for any nugget of additional context.
After advancing in lockstep through the pandemic, the fortunes of the biotechs have diverged as their use of COVID-19 windfalls has taken shape.
After suffering in the wake of expired tax incentives for pharmas, the island is trying to take advantage of geopolitics to grow its drug manufacturing sector.
Subscribe to BioPharm Executive
Market insights and trending stories for biopharma leaders, in your inbox every Wednesday
THE LATEST
La Jolla Pharmaceutical Company, a leader in the discovery, development and commercialization of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases, announced that George Tidmarsh, M.D., Ph.D., President and Chief Executive Officer, has left the Company to pursue other interests.
Beyond Air, Inc. announced an exclusive five-year global supply agreement for NO and NO2 calibration gas with MESA Specialty Gases & Equipment.
Artelo Biosciences, Inc., a clinical stage biopharmaceutical company focused on the development of therapeutics that modulate the endocannabinoid system, reported financial and operating results for the fourth quarter and fiscal year ended August 31, 2019 and provided a business update.
Agios Pharmaceuticals, Inc., a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, announced the appointment of Jonathan Biller to the newly created role of chief legal officer effective December 3, 2019.
PCI Biotech, a cancer focused biopharmaceutical company announces its third quarter 2019 result.
H.E.L. Group announced the strengthening of the Company’s senior management team with Paul Orange, Ph.D. joining as Chief Marketing Officer, and Paul Sturgeon as Chief Financial Officer.
Azzur Welcomes Tita Tavares as Director of Its New Office in Washington, D.C.
The press release will be available on the Company’s website (www.kewaunee.com) after it has been issued.
Imagine if an ultrasound could be used as a quantitative tool to measure fat in the liver and detect non-alcoholic fatty liver disease. What seems imaginative is close to becoming reality at Endra Life Sciences.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.